Short-term Antibiotic Therapy for Pyelonephritis in Childhood
Status:
Terminated
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of oral ceftibuten for 7 days versus 10
days in acute pyelonephritis in children.
The main hypothesis is that the ceftibuten for 7 days will be not inferior to ceftibuten 10
days in the rate of renal scarring at 6-12 months.